Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Apr 29;6(4):e010324.
doi: 10.1136/bmjopen-2015-010324.

Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis

Antoine Elias et al. BMJ Open. .

Abstract

Objective: To review the evidence for existing prognostic models in acute pulmonary embolism (PE) and determine how valid and useful they are for predicting patient outcomes.

Design: Systematic review and meta-analysis.

Data sources: OVID MEDLINE and EMBASE, and The Cochrane Library from inception to July 2014, and sources of grey literature.

Eligibility criteria: Studies aiming at constructing, validating, updating or studying the impact of prognostic models to predict all-cause death, PE-related death or venous thromboembolic events up to a 3-month follow-up in patients with an acute symptomatic PE.

Data extraction: Study characteristics and study quality using prognostic criteria. Studies were selected and data extracted by 2 reviewers.

Data analysis: Summary estimates (95% CI) for proportion of risk groups and event rates within risk groups, and accuracy.

Results: We included 71 studies (44,298 patients). Among them, 17 were model construction studies specific to PE prognosis. The most validated models were the PE Severity Index (PESI) and its simplified version (sPESI). The overall 30-day mortality rate was 2.3% (1.7% to 2.9%) in the low-risk group and 11.4% (9.9% to 13.1%) in the high-risk group for PESI (9 studies), and 1.5% (0.9% to 2.5%) in the low-risk group and 10.7% (8.8% to12.9%) in the high-risk group for sPESI (11 studies). PESI has proved clinically useful in an impact study. Shifting the cut-off or using novel and updated models specifically developed for normotensive PE improves the ability for identifying patients at lower risk for early death or adverse outcome (0.5-1%) and those at higher risk (up to 20-29% of event rate).

Conclusions: We provide evidence-based information about the validity and utility of the existing prognostic models in acute PE that may be helpful for identifying patients at low risk. Novel models seem attractive for the high-risk normotensive PE but need to be externally validated then be assessed in impact studies.

Keywords: prediction rules; prognostic models; pulmonary embolism; risk stratification; systematic review.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of search results.
Figure 2
Figure 2
sROC plots showing test accuracy of PESI≥III cut-off associated with 30-day all-cause death: all studies (A) and external validation studies (B). HSROC, hierarchical summary receiver operating characteristic; PESI, Pulmonary Embolism Severity Index; sROC, summary receiver operating characteristic.
Figure 3
Figure 3
sROC plots showing test accuracy of sPESI≥1 cut-off associated with 30-day all-cause death: all studies (A) and external validation studies (B). HSROC, hierarchical summary receiver operating characteristic; PESI, Pulmonary Embolism Severity Index; sROC, summary receiver operating characteristic.

References

    1. Torbicki A, Perrier A, Konstantinides S et al. . Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29:2276–315. 10.1093/eurheartj/ehn310 - DOI - PubMed
    1. Jaff MR, McMurtry MS, Archer SL et al. . Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123:1788–830. 10.1161/CIR.0b013e318214914f - DOI - PubMed
    1. Konstantinides SV, Torbicki A, Agnelli G et al. . 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033–69, 69a-69k. - PubMed
    1. Kearon C, Akl EA, Ornelas J et al. . Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016;149:315–52. 10.1016/j.chest.2015.11.026 - DOI - PubMed
    1. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007;116:427–33. 10.1161/CIRCULATIONAHA.106.680421 - DOI - PubMed